LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
31 funds hold it · Insiders net selling
Net selling: insiders sold $3.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Oct 29, 2026
Financial period
Third-Quarter 2026
GAAP EPS
Company release
Revenue
$499.5M expected
EPS comparison unavailable.
Full-Year 2026 BRINSUPRI guidance
$1.35B to $1.40B
No comparable estimate
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Oct 29, 2026 | $0.46Company GAAP | Not comparableDifferent EPS measure | $524.4Mest. $499.5M+4.99% | +268.4%from $142.3M |
| Jun 30, 2026Reported Aug 6, 2026 | -$0.06est. -$0.68 | +91.21%beat | $425.5Mest. $393.4M+8.17% | +296.1%from $107.4M |
| Mar 31, 2026Reported May 7, 2026 | -$0.76est. -$1.00 | +23.93%beat | $306.0MCompany release | +229.7%from $92.8M |
| Dec 31, 2025Reported Feb 19, 2026 | -$1.54est. -$1.17 | -31.92%miss | $263.8MAlpha Vantage | +152.6%from $104.4M |
| Sep 30, 2025Reported Oct 30, 2025 | -$1.75est. -$1.37 | -27.74%miss | $142.3MSEC filing | +52.4%from $93.4M |
| Jun 30, 2025Reported Aug 7, 2025 | -$1.70est. -$1.30 | -30.77%miss | $107.4MSEC filing | +18.9%from $90.3M |
| Mar 31, 2025Reported May 8, 2025 | -$1.42est. -$1.20 | -18.33%miss | $92.8MSEC filing | +22.9%from $75.5M |
| Dec 31, 2024Reported Feb 20, 2025 | -$1.32est. -$1.23 | -7.32%miss | $104.4MAlpha Vantage | +24.8%from $83.7M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $263.8M | $306.0M | $425.5M | $524.4M |
| Cost of what it sold | $44.2M | $49.5M | $67.2M | $78.2M |
| Gross profit | $219.6M | $256.5M | $358.3M | $446.2M |
| What it spent | ||||
| Research and development | $254.9M | $209.5M | $210.0M | $270.0M |
| Sales and admin | $212.5M | $247.3M | $247.5M | $253.0M |
| Other operating costs | — | — | -$97.7M | $12.6M |
| Total operating expenses | $469.3M | $456.7M | $359.8M | $535.6M |
| What was left | ||||
| Operating profit | -$249.7M | -$200.3M | -$1.5M | -$89.4M |
| Interest on debt | $20.6M | $20.1M | $20.3M | $20.4M |
| Profit before tax | -$326.9M | -$162.1M | -$11.4M | -$97.7M |
| Tax | $1.6M | $1.5M | $1.9M | $2.7M |
| Net profit | -$328.5M | -$163.6M | -$13.2M | -$100.3M |
| EBITDA | -$302.1M | -$137.1M | $14.2M | -$68.8M |
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Is Insmed Stock Paying You Enough For The Swings?
Leans bearishNov 11Here’s How Much You Would Have Made Owning Insmed Stock In The Last 5 Years
BullishNov 11Insmed (INSM) Raises 2026 Guidance Following Earnings, Is It Still Below Fair Value?
Leans bullishNov 7Insmed Incorporated (INSM) Seasonal Returns Chart - Yahoo Finance
NeutralNov 7Insmed to Present at November and December 2026 Investor Conferences
NeutralNov 4Two Insmed talks will stream live from London and Florida
NeutralNov 4H.C. Wainwright initiates Insmed stock coverage with buy rating By Investing.com
BullishNov 4Insmed to present at major healthcare conferences in London and Florida in November-December 2026
Leans bullishNov 4
